Treatment options and considerations for hypertensive patients to prevent dementia

Expert Opin Pharmacother. 2017 Jul;18(10):989-1000. doi: 10.1080/14656566.2017.1333599. Epub 2017 May 29.

Abstract

Dementia is a worldwide health concern, which leads to loss of autonomy. To date no curative treatment is available so focus on modifiable risk factors is of particular interest. Hypertension, particularly midlife high blood pressure, has been associated with an increased risk for cognitive decline and dementia including vascular dementia (VAD) and Alzheimer disease (AD). In this context, antihypertensive treatments might have a preventive effect. The objective of this review was to examine the relationship between antihypertensive therapy and cognitive decline or dementia. Areas covered: A literature search was conducted using PUBMED and the COCHRANE LIBRARY for publications from 1990 onwards mentioning cognitive decline, AD, Vad, mixed dementia, vascular cognitive impairment, hypertension and antihypertensive therapy. Thirty-nine relevant publications including 20 longitudinal studies, 10 randomized-controlled trials and 9 meta-analyses were taken into account. Expert opinion: Most observational studies have suggested a potential preventive effect of antihypertensive therapies on cognitive decline and dementia, particularly calcium channel blockers and renin-angiotensin system blockers. Randomized clinical trials and meta-analyses provided more conflicting results potentially due to methodological issues. In conclusion, antihypertensive therapies may reduce cognitive decline and incidence of dementia. Further randomized clinical trials conducted in populations at higher risk of cognitive decline, with longer periods of follow-up and cognition as the primary outcome are still needed.

Keywords: Alzheimer’s disease; antihypertensive therapy; cognitive decline; dementia; hypertension; longitudinal studies; meta-analysis; randomized controlled trials.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / complications
  • Alzheimer Disease / prevention & control*
  • Antihypertensive Agents / therapeutic use*
  • Calcium Channel Blockers / therapeutic use
  • Cognition Disorders / complications
  • Cognition Disorders / prevention & control
  • Database Management Systems
  • Dementia, Vascular / complications
  • Dementia, Vascular / prevention & control*
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy*
  • Meta-Analysis as Topic
  • Randomized Controlled Trials as Topic
  • Renin-Angiotensin System / drug effects
  • Risk Factors

Substances

  • Antihypertensive Agents
  • Calcium Channel Blockers